380 related articles for article (PubMed ID: 12420343)
1. [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS].
Halota W; Jaruga B; Pawłowska M
Pol Merkur Lekarski; 2002 Aug; 13(74):126-8. PubMed ID: 12420343
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
3. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A
Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488
[TBL] [Abstract][Full Text] [Related]
4. Laboratory markers associated with progression of HIV infection.
Kiepiela P; Smith AN; Rosenberg E
Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):243-54. PubMed ID: 15778113
[TBL] [Abstract][Full Text] [Related]
5. Beta-2-microglobulin, neopterin and monocyte Fc gamma receptors in opportunistic infections of HIV-positive patients.
Dunne J; Feighery C; Whelan A
Br J Biomed Sci; 1996 Dec; 53(4):263-9. PubMed ID: 9069103
[TBL] [Abstract][Full Text] [Related]
6. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
Mildvan D; Spritzler J; Grossberg SE; Fahey JL; Johnston DM; Schock BR; Kagan J
Clin Infect Dis; 2005 Mar; 40(6):853-8. PubMed ID: 15736019
[TBL] [Abstract][Full Text] [Related]
7. CD4+:neopterin ratio correlates with p24 antigenaemia in HIV infected patients.
Crocchiolo PR; Lizioli A; Cantaluppi P; Filippi C; D'Agostino F; Cambié G; Panzeri MP; Nardella ML
J Clin Lab Immunol; 1990 Feb; 31(2):55-7. PubMed ID: 1983767
[TBL] [Abstract][Full Text] [Related]
8. Behaviour of different clinical, immunological and serological parameters observed in a group of HIV positive patients during a 12 month treatment period with zidovudine.
Crocchiolo PR; Lizioli A; Arcidiacono I; Cantaluppi P; Filippi C; Sobatti D; Bedarida G; D'Agostino F; Cambie G; Nardella ML
Boll Ist Sieroter Milan; 1990 Jun; 69(2):423-30. PubMed ID: 1983798
[TBL] [Abstract][Full Text] [Related]
9. [The prognostic markers of HIV infection progression. A study of the p24 antigen in a cohort of 251 patients].
Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T
An Med Interna; 1999 Sep; 16(9):447-50. PubMed ID: 10609356
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of various biological markers in HIV 1 infection].
Serra JE; Pombo V; Côrte-Real R; da Cunha S; Meliço-Silvestre A
Acta Med Port; 1993 Jan; 6(1):5-9. PubMed ID: 8097351
[TBL] [Abstract][Full Text] [Related]
11. Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users.
Rezza G; Titti F; Pezzotti P; Sernicola L; Lo Caputo S; Angarano G; Lazzarin A; Sinicco A; Rossi GB; Verani P
J Biol Regul Homeost Agents; 1992; 6(1):15-20. PubMed ID: 1359736
[TBL] [Abstract][Full Text] [Related]
12. [Serum adenosine deaminase in human immunodeficiency virus infection. Its relationship with CD4+ lymphocytes and beta 2-microglobulin].
Iñigo MA; Ruiz López de Tejada M; Torres-Tortosa M; Sánchez-Porto A; Ugarte I; García de Lomas E; Morán Nestares A
Med Clin (Barc); 1992 Dec; 99(20):766-8. PubMed ID: 1361013
[TBL] [Abstract][Full Text] [Related]
13. The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels.
Sheppard HW; Lang W; Ascher MS; Vittinghoff E; Winkelstein W
AIDS; 1993 Sep; 7(9):1159-66. PubMed ID: 8105806
[TBL] [Abstract][Full Text] [Related]
14. Serum IgD behaviour in HIV-1 infected patients.
Raiteri R; Albonico M; Deiana R; Marietti G; Sinicco A
Allergol Immunopathol (Madr); 1991; 19(1):6-10. PubMed ID: 1950942
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of several markers in the progression to acquired immunodeficiency syndrome.
Planella T; Cortés M; Martínez-Brú C; Barrio J; Sambeat MA; González-Sastre F
Clin Chem Lab Med; 1998 Mar; 36(3):169-73. PubMed ID: 9589805
[TBL] [Abstract][Full Text] [Related]
16. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
[TBL] [Abstract][Full Text] [Related]
17. Surrogate markers for AIDS treatment.
Jacobson M
Nurs Times; 1991 May 29-Jun 4; 87(22):49. PubMed ID: 1675013
[No Abstract] [Full Text] [Related]
18. Comparative study of various biological markers in infection by HIV1.
Serra JE; Pombo V; Côrte-Real R; Da Cunha S; Meliço-Silvestre A
Acta Med Port; 1994 Dec; 7 Suppl 1():S9-14. PubMed ID: 7653284
[TBL] [Abstract][Full Text] [Related]
19. [Study on serum neopterin concentration in hemophiliacs with anti-human immunodeficiency-virus type I antibody].
Matsuda J
Rinsho Byori; 1991 Jul; 39(7):743-7. PubMed ID: 1920867
[TBL] [Abstract][Full Text] [Related]
20. Beta2 microglobulin as a surrogate marker for HIV infection: good correlation with CD4 counts.
Wanchu A; Arora S; Bhatnagar A; Sud A; Bambery P; Singh S
Indian J Pathol Microbiol; 2004 Apr; 47(2):298-301. PubMed ID: 16295507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
